세계의 골반 내 염증성 질환(PID) 치료 시장 보고서(2025년)

Pelvic inflammatory disease (PID) treatment involves the medical management of infections affecting the female reproductive organs, typically caused by sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae. The goal of treatment is to eliminate the infection, alleviate symptoms, and prevent complications such as infertility, chronic pelvic pain, and ectopic pregnancy.

The main types of PID treatment include antibiotic therapy, surgery, pain management, and hormonal therapy. Antibiotic therapy involves using antibiotics to treat bacterial infections by killing or inhibiting the growth of bacteria. It can be administered orally, intravenously, or intramuscularly, and PID treatment is available in hospitals, clinics, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pelvic inflammatory disease (PID) treatment market research report is one of a series of new reports from The Business Research Company that provides pelvic inflammatory disease (PID) treatment market statistics, including the pelvic inflammatory disease (PID) treatment industry global market size, regional shares, competitors with the pelvic inflammatory disease (PID) treatment market share, detailed pelvic inflammatory disease (PID) treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the pelvic inflammatory disease (PID) treatment industry. This pelvic inflammatory disease (PID) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pelvic inflammatory disease (pid) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the growing adoption of telemedicine, rising incidence of sexually transmitted infections, increasing cases of sexually transmitted infections (STIs), rising awareness of pelvic inflammatory disease, and increasing healthcare expenditure.

The pelvic inflammatory disease (pid) treatment market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing prevalence of sexually transmitted infections, rising awareness regarding women's reproductive health, raising awareness about pelvic inflammatory disease, increasing reliance on telehealth services, and rising incidence of sexually transmitted infections (STIs). Major trends in the forecast period include innovative pelvic inflammatory disease treatment products, advancements in diagnostic technologies, innovations such as personalized treatment, advanced imaging techniques, and technological advancements.

The forecast of 5.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. antibiotic access by increasing costs for broad-spectrum IV antibiotics and pelvic ultrasound equipment imported from India and the Netherlands, potentially delaying Pelvic Inflammatory Disease treatment and raising Obstetrics and Gynecology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of sexually transmitted infections (STIs) is expected to drive the growth of the pelvic inflammatory disease (PID) treatment market. STIs are infections caused by bacteria, viruses, or parasites that are primarily spread through sexual contact, including vaginal, anal, or oral sex. The increasing prevalence of STIs is attributed to factors such as risky sexual behaviors, unprotected sex, lack of awareness, and delayed testing and treatment. PID treatment is crucial for managing STIs, as it involves the use of antibiotics to eliminate the bacteria causing the infection, preventing complications such as chronic pelvic pain and infertility, and reducing the risk of recurrent infections. For example, in October 2024, a report from the UK Health Security Agency (UKHSA) revealed that in 2023, England recorded 6,008 new HIV diagnoses, marking a 51% increase compared to 3,975 in 2022. Therefore, the growing prevalence of STIs is driving the expansion of the PID treatment market.

Companies operating in the pelvic inflammatory disease (PID) treatment market are focusing on developing innovative formulations, such as probiotic supplements, to enhance treatment efficacy, restore vaginal microbiota balance, and reduce the recurrence of infections in PID patients. Probiotic supplements contain beneficial live bacteria or yeasts that help maintain or restore a healthy balance of the gut and vaginal microbiota. For example, in November 2024, Lee Health Domain, an India-based pharmaceutical company, launched V-Ferin, a probiotic supplement aimed at supporting vaginal health. Formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, V-Ferin seeks to restore the natural microbiome and prevent common vaginal infections such as bacterial vaginosis and yeast infections. With approximately 25-30% of women affected by these conditions, which can lead to PID if left untreated, V-Ferin offers an innovative solution to improve health and prevent complications.

In February 2022, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Panacea Biotec Limited (PBL) for $212.88 million. This acquisition strengthens Mankind Pharma's position in the chronic and transplant business by integrating well-researched formulations and leveraging advanced technology and niche expertise, while retaining Panacea Biotec's sales and marketing team to ensure seamless business operations and market expansion. Panacea Biotec Limited is an India-based biotechnology company that develops, manufactures, and commercializes pharmaceuticals, vaccines, and biosimilars for various diseases, including pelvic inflammatory disease (PID).

Major players in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., and Amagen India Life Sciences.

North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pelvic inflammatory disease (PID) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pelvic inflammatory disease (PID) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pelvic inflammatory disease (PID) treatment market consists of revenues earned by entities by providing services such as medication therapy, pain management, and hospital and clinic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pelvic inflammatory disease (PID) treatment market includes sales of antibiotics, pain relievers, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pelvic inflammatory disease (pid) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pelvic inflammatory disease (pid) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pelvic inflammatory disease (pid) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
• 2) By Route Of Administration: Oral; Intravenous; Intramuscular
• 3) By End User: Hospitals; Clinics; Homecare
• Subsegments:
• 1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
• 2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
• 3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
• 4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy
• Companies Mentioned: Pfizer Inc.; Bayer AG; Eli Lilly and Company; Otsuka Pharmaceutical Co. Ltd.; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Hetero Drugs Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Dr. Reddy's Laboratories Ltd.; Cipla Limited; Hikma Pharmaceuticals PLC; Lupin Pharmaceuticals Inc.; Torrent Pharmaceuticals Ltd.; Mankind Pharma Ltd.; Mayne Pharma Group Limited; Saphnix Lifesciences; Aristo Pharmaceuticals Pvt. Ltd.; Zydus Cadila Healthcare Ltd.; Amagen India Life Sciences.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pelvic Inflammatory Disease (PID) Treatment Market Characteristics

3. Pelvic Inflammatory Disease (PID) Treatment Market Trends And Strategies

4. Pelvic Inflammatory Disease (PID) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pelvic Inflammatory Disease (PID) Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pelvic Inflammatory Disease (PID) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pelvic Inflammatory Disease (PID) Treatment Market Growth Rate Analysis
• 5.4. Global Pelvic Inflammatory Disease (PID) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pelvic Inflammatory Disease (PID) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pelvic Inflammatory Disease (PID) Treatment Total Addressable Market (TAM)

6. Pelvic Inflammatory Disease (PID) Treatment Market Segmentation

• 6.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotic Therapy
• Surgery
• Pain Management
• Hormonal Therapy
• 6.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• 6.3. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• 6.4. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Broad-spectrum Antibiotics
• Combination Antibiotic Therapy
• Oral Antibiotics
• Intravenous Antibiotics
• 6.5. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laparoscopy
• Hysterectomy
• Tubal Surgery
• 6.6. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Pain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Opioid Analgesics
• Acetaminophen
• Localized Pain Management
• 6.7. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Birth Control Pills
• Hormonal Intrauterine Device (IUD)
• Progesterone Therapy

7. Pelvic Inflammatory Disease (PID) Treatment Market Regional And Country Analysis

• 7.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market

• 8.1. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pelvic Inflammatory Disease (PID) Treatment Market

• 9.1. China Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 9.2. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pelvic Inflammatory Disease (PID) Treatment Market

• 10.1. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pelvic Inflammatory Disease (PID) Treatment Market

• 11.1. Japan Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 11.2. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pelvic Inflammatory Disease (PID) Treatment Market

• 12.1. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market

• 13.1. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pelvic Inflammatory Disease (PID) Treatment Market

• 14.1. South Korea Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 14.2. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market

• 15.1. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 15.2. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pelvic Inflammatory Disease (PID) Treatment Market

• 16.1. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pelvic Inflammatory Disease (PID) Treatment Market

• 17.1. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pelvic Inflammatory Disease (PID) Treatment Market

• 18.1. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pelvic Inflammatory Disease (PID) Treatment Market

• 19.1. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pelvic Inflammatory Disease (PID) Treatment Market

• 20.1. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market

• 21.1. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 21.2. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pelvic Inflammatory Disease (PID) Treatment Market

• 22.1. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pelvic Inflammatory Disease (PID) Treatment Market

• 23.1. North America Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 23.2. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pelvic Inflammatory Disease (PID) Treatment Market

• 24.1. USA Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 24.2. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pelvic Inflammatory Disease (PID) Treatment Market

• 25.1. Canada Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 25.2. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pelvic Inflammatory Disease (PID) Treatment Market

• 26.1. South America Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 26.2. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pelvic Inflammatory Disease (PID) Treatment Market

• 27.1. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pelvic Inflammatory Disease (PID) Treatment Market

• 28.1. Middle East Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 28.2. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pelvic Inflammatory Disease (PID) Treatment Market

• 29.1. Africa Pelvic Inflammatory Disease (PID) Treatment Market Overview
• 29.2. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape
• 30.2. Pelvic Inflammatory Disease (PID) Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pelvic Inflammatory Disease (PID) Treatment Market Other Major And Innovative Companies

• 31.1. Daiichi Sankyo Company Limited
• 31.2. Hetero Drugs Ltd.
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Takeda Pharmaceutical Company Limited
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Limited
• 31.7. Hikma Pharmaceuticals PLC
• 31.8. Lupin Pharmaceuticals Inc.
• 31.9. Torrent Pharmaceuticals Ltd.
• 31.10. Mankind Pharma Ltd.
• 31.11. Mayne Pharma Group Limited
• 31.12. Saphnix Lifesciences
• 31.13. Aristo Pharmaceuticals Pvt. Ltd.
• 31.14. Zydus Cadila Healthcare Ltd.
• 31.15. Amagen India Life Sciences

32. Global Pelvic Inflammatory Disease (PID) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pelvic Inflammatory Disease (PID) Treatment Market

34. Recent Developments In The Pelvic Inflammatory Disease (PID) Treatment Market

35. Pelvic Inflammatory Disease (PID) Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer